- Bitcoin Holds $78K After 24% August Rally: Is a September Correction Coming?
- Grayscale Says Bitcoin May Benefit Less Than Ethereum, Solana if CLARITY Act Passes
- Attackers drain 15.5M WFLOW from More Markets in suspected $9.3M Flow exploit
- Ayman ‘AiMan’ Mufleh projects HBAR could reach $6.76 if it matches Ethereum’s market cap
- Update: Market Chatter: SK Hynix Denies Report of Intel Foundry Partnership for HBM4E
- Qnity Electronics Unveils Stackplane Platform for Advanced Packaging
- Goldman Sachs lifts Hugo Boss voting rights to 17.63% from 16.96%
- Happy City net loss widens to US$ 2.62 million in 1H FY26; revenue drops 44.2% to US$ 2.32 million
- Excellon defines seven exploration targets at Peru’s Tres Cerros, with grab samples up to 14 g/t gold and 9,050 g/t silver
- South Pacific Metals reports outcrop assays up to 12.8% copper at Kili Teke project in Papua New Guinea outside resource area
- Radware COO Gabriel Malka sells 6,500 shares for $195,000
- A-6684 reports purchase of 5,000 Tofutti Brands common shares worth $2,250
- UMH Properties secures $10.2 million Fannie Mae mortgage via Wells Fargo at 6.03% fixed rate
- BUZZ-BTIG hikes PT on GitLab, citing software market trends
- Royal Road Minerals launches C$ 1 million private placement at C$ 0.2 per share
- Russia Opens Legal Crypto Trading, but Retail Investors Face $3,800 Limit
- Alzamend Neuro director Milton C. Ault III sells 2,000 shares worth $3,116.20
- Kratos wins $35 million national security hardware production award
- Malibu Boats corrects Q4 adjusted EBITDA to USD 31.39 million after acquisition cost error
- OneConstruction Group director Kong Xiangming files initial beneficial ownership statement
- --GUIDANCE:(SAIC) Science Applications International Expects Fiscal 2027 Adjusted EPS Range $10.65 - $10.75, vs. FactSet Est of $10.18
- --Earnings Flash (SAIC) Science Applications International Posts Fiscal Q2 Revenue $1.88B, vs. FactSet Est of $1.76B
- RedHill Biopharma: Apotex Will Receive RedHill's 70% Interest in Talicia, Following Apotex's Prior Acquisition of Cumberland Pharmaceuticals' U.S. Branded Business >RDHL
- GDEV launches self-tender offer to buy up to USD 20 million of shares at USD 11.03 each
- BioLineRx Q2 FY26 net loss widens to USD 4.3 million; R&D expenses rise 26.5% to USD 2.9 million
- Ascendis enters global settlement, license deal with BioMarin for YUVIWEL royalties
- Pulsenmore H1 FY26 comprehensive loss widens 51% to NIS 35 million; revenue rises 53% to NIS 6.1 million
- Goldera launches 2026 exploration at Egan Gold project, targets late Q3-Q4 drilling
- Nordnet buys back 96,721 LTIP 2023/2026 warrants, issues 45,267 shares as consideration
- Hepion Pharmaceuticals files draft information statement for shareholders
- TELA Bio COO and CFO Roberto Cuca steps down
- PyroGenesis wins second titanium powder order worth US$73,700 from US additive manufacturing OEM
- RBC Raises Price Target on Mastercard to $696 From $642, Keeps Outperform Rating
- Helium Evolution shares gain DTC eligibility for U.S. electronic trade settlement
- Trianon CEO Kruger presents at Stockholm Corporate Finance Real Estate Day
- RedHill Biopharma sells Talicia stake to Apotex for $18 million upfront, up to $35 million milestones
- aTyr Pharma announces special shareholder meeting
- AB Volvo reports 2.03 billion shares outstanding, 600 million votes as of Aug. 31
- Seaport Therapeutics participates in Citi Biopharma Back to School conference fireside chat
- Summit Midstream unit Double E signs long-term transport deal for 200 MMcf/d capacity
- Noah Holdings director Zhang Tianjing files initial beneficial ownership statement
- Alamos Gold director Claire Kennedy exits board after Canada consul general appointment
- Palladyne AI CEO, CFO to join Jefferies Global Industrials Conference fireside chat
- Neo Performance Materials partners with Carester to secure European heavy rare earth supply chain
- Security Concerns on an Altcoin Network: Mainnet Block Production Halted
- Sweetgreen adopts severance plan with change-in-control payouts for top executives
- Sea President Feng Zhimin disposes of Sea shares worth $495,772.2
- Markets pivot to September Fed rate hike: Five things to know in Bitcoin this week
- Eli Lilly to Bay Merida Biosciences For Up to $2.875 Billion
- RBC Raises Price Target on Lightspeed Commerce to $13 From $10, Keeps Outperform Rating
- AITX unit RAD books orders for 32 security hardware units in August
- Clough Global Equity Fund pays $0.07 per share monthly distribution
- Reaves Utility Income Fund pays monthly distribution of $0.21 a share
- Clough Global Opportunities Fund pays $0.05 monthly distribution per share
- Kazia Therapeutics launches registered public offering of ADSs and warrants
- Clough Global Dividend and Income Fund pays $0.06 per share monthly distribution
- Northann faces NYSE American delisting proceedings over listing-rule breach
- RBC Raises Price Target on Global Payments to $106 From $102, Keeps Sector Perform Rating
- Alterity Therapeutics issues shares from exercise of listed options at A$0.5 each
- LIVE MARKETS-Goldman takes a factor approach to FX markets
- Honda, Nissan partner to standardize ECUs and software for next-generation SDVs
- FIVE9, INC. <FIVN.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $40 FROM $35
- IperionX wins second U.S. Army SBIR task order worth up to US$25.4 million
- RBC Raises Price Target on Shift4 Payments to $67 From $63, Keeps Outperform Rating
- SemiLEDs holds annual shareholder meeting
- HDFC Bank CEO Sashidhar Jagdishan declines reappointment, to retire Oct. 26, 2026
- US STOCKS-US stock futures down as Middle East strikes fuel inflation anxiety
- USP Group audited FY2022 revenue falls 3.8% to S$ 39.39 million from unaudited results
- KKR posts “Sale of USI Insurance Services to Aon” presentation on website
- GameStop Expects Higher 2Q Profit, Despite Lower Sales -- Update
- Zedge Appoint Morris Berger as Chief Executive Officer, Effective Oct 1 >ZDGE
- USP Group auditor disclaims opinion on FY2022-FY2024 accounts amid ongoing trading suspension
- Ranger Energy Services to Acquire STEP's US Coiled Tubing Assets
- RBC Raises Price Target on Flywire to $25 From $20, Keeps Outperform Rating
- Blossom Gold Starts Drilling at Kamma Claims in Nevada
- SLB to acquire Kelvion for $3.4 billion
- Pacific Booker engages Tetra Tech for Morrison copper-gold project pre-feasibility study
- Deckers Outdoor amends revolver, boosts commitments to USD 500 million
- eQ says SpaceX IPO marks first major liquidity event for venture capital portfolio
- Ecopetrol calls extraordinary shareholders meeting in Bogota
- Royale Energy Q2 FY26 net loss widens to $813,118; revenue rises 94.5% to $669,655
- Royal Bank of Canada Notches Solid Quarter; Strength Seen Reflected in Valuation -- Market Talk
- RBC Raises Price Target on Corpay to $438 From $423, Keeps Sector Perform Rating
- Danske Bank unit Realkredit Danmark sets spread on mortgage-covered bond refinancing due Oct. 2026
- SLB agrees to buy Kelvion for $3.4 billion, assumes $0.7 billion debt
- Nomura publishes 2026 annual report
- Herbalife CFO DeSimone to serve as interim CEO from Nov. 1, 2026
- --Needham Initiates Babcock & Wilcox Enterprises at Buy
- Eli Lilly to buy Merida Biosciences in $2.88 billion deal
- Aon Strikes Roughly $17 Billion Deal for Insurance Brokerage USI -- Update
- SLB to Buy Acquire Kelvion From Majority Owner Apollo, Funds Advised by Triton >SLB APO
- Jazz Pharmaceuticals Phase 3 Trial Shows Survival Benefit for Ziihera in Gastroesophageal Cancer
- Apollo funds agree to sell Kelvion to SLB for $4.1 billion
- Brazil court grants Grupo Casas Bahia early stay protection in judicial reorganization case
- Canadian Jobs Growth Expected to Slow in August but Outlook Remains for Gradual Improvement, RBC Says
- Ladenburg Thalmann Adjusts Price Target on Sempra to $98 From $102.50, Maintains Buy Rating
- SLB to Buy Kelvon For About $3.4 Billion Cash >SLB APO
- PAYPAL : CLEAR STREET CUTS TARGET PRICE TO $55 FROM $61
- Lilly to acquire Merida Biosciences in deal worth up to USD 2.88 billion
- PG&E CORP : BMO CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $21 FROM $28
